Dexin (ROCO:3349) EBIT per Share : NT$-0.53 (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Dexin EBIT per Share?

Dexin's EBIT per Share for the three months ended in Mar. 2025 was NT$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.53.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Dexin's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Dexin was 71.20% per year. The lowest was -77.30% per year. And the median was -8.30% per year.

ROCO:3349's 3-Year EBIT Growth Rate is not ranked ^*
in the Hardware industry.
Industry Median: 1.15
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Dexin's EBIT for the three months ended in Mar. 2025 was NT$-0.5 Mil.

Dexin EBIT per Share Historical Data

The historical data trend for Dexin's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dexin EBIT per Share Chart

Dexin Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.66

2.17

-0.98

-2.52

-0.95

Dexin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															-0.44	0.05	-0.65	0.09	-0.01

Dexin EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Dexin's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-38.354	/	40.269
=	-0.95

Dexin's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.537	/	40.269
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.53

Dexin (ROCO:3349) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Dexin EBIT per Share Related Terms

Thank you for viewing the detailed overview of Dexin's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Dexin Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Dexin Corp (ROCO:3349) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

14F-8, No.258, Liancheng Road, Zhonghe District, New Taipei, TWN, 235

Website

http://www.dexin.com.tw

Dexin Corp is a Taiwan-based company engages in the manufacture and sale of information technology (IT) input devices in Taiwan. It focuses on various cordless and corded products, such as laser mouse, optical mouse, gaming mouse, keyboard mouse set, Web camera, and Skype phone.

Dexin Headlines

No Headlines